MedTrace Logo

Safety and Tolerability of Artificial Tears in Dry Eye Subjects

NCT00932477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2015-08-26

Study results available
· View outcomes & findings →

Summary

The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.

Conditions

  • Dry Eye Syndrome

Interventions

DRUG

Formulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear

1 to 2 drops into each eye three times per day

DRUG

Formulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear

1 to 2 drops into each eye three times per day

DRUG

Glycerin and Polysorbate 80 based artificial tear

1 to 2 drops into each eye three times per day

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00932477 on ClinicalTrials.gov